Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
97 Results for "
ATP synthase
" in MedChemExpress (MCE) Product Catalog:
Products (97)
97 Results for "ATP synthase" in MCE Product Catalog:
Cat. No.: HY-P82954A
Synonyms: LIG4; DNA ligase 4; DNA ligase IV; Polydeoxyribonucleotide synthase [ATP] 4
Cat. No.: HY-111651R
CAS No.: 2101315-36-8
Research Areas:
Gboxin (Standard) is the analytical standard of Gboxin (HY-111651). This product is intended for research and analytical applications. Gboxin is an oxidative phosphorylation (OXPHOS) inhibitor that targets glioblastoma. Gboxin inhibits the activity of F0F1 ATP synthase. Antitumour activity .
Cat. No.: HY-E72022
Target:
Research Areas:
8-Demethylnovobiocic acid synthase (EC 6.3.1.15) is a ligase that can convert 3-amino-4,7-dihydroxycoumarin, 3-dimethylallyl-4-hydroxybenzoate and ATP into 8-desmethylnovobiocic acid, AMP and diphosphate.
Cat. No.: HY-E71996
Target:
Research Areas:
7-Cyano-7-deazaguanine synthase (EC 6.3.4.20) is a ligase that can convert 7-carboxy-7-carbaguanine, NH4 + and 2 ATP into 7-cyano-7-carbaguanine, 2 AMP, 2 diphosphate and 2 H +.
Cat. No.: HY-E71891
Target:
Research Areas:
5-(Carboxyamino)Imidazole ribonucleotide synthase (EC 6.3.4.18) is a ligase that can convert 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole, hydrogencarbonate and ATP into 5-carboxyamino-1-(5-phospho-D-ribosyl)imidazole, ADP, phosphate and 2 H +.
Cat. No.: HY-180149
Target:
Research Areas:
PRP020 is a potent and specific inhibitor of mycobacterial ATP synthase. PRP020 does not inhibit acidification driven by succinate. PRP020 exihibits MIC95 against M. tuberculosis of 2 μM, and it remains active against most drug-resistant mutant strains. PRP020 is highly safe and can be used in anti-tuberculosis research .
Cat. No.: HY-P810967
Synonyms: ATP6IP2, CAPER, ELDF10, HT028, MSTP009, PSEC0072, ATP6AP2, Renin receptor, ATPase H(+)-transporting lysosomal accessory protein 2, ATPase H(+)-transporting lysosomal-interacting protein 2, ER-localized type I transmembrane adapter, Embryonic liver differentiation factor 10, N14F, Renin/prorenin receptor, Vacuolar ATP synthase membrane sector-associated protein M8-9, ATP6M8-9, V-ATPase M8.9 subunit
Cat. No.: HY-187350
Research Areas:
LRPPRC-IN-1 is a LRPPRC inhibitor. LRPPRC-IN-1 exerts dual effects of inhibiting LRPPRC activity and inducing its degradation by binding to the RNA-binding domain of LRPPRC. LRPPRC-IN-1 downregulates the expression of mitochondrial OXPHOS complex subunits and ATP synthase, inhibits oxidative phosphorylation, reduces ATP production, suppresses the proliferation and colony formation of various cancer cells, and inhibits tumor growth in vivo. LRPPRC-IN-1 can be used in studies related to lung cancer, pancreatic cancer, breast cancer, esophageal cancer, colorectal cancer, lymphoma, melanoma, cervical cancer, ovarian cancer, and prostate cancer .
Cat. No.: HY-P705540
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: ATPSCKMT; Protein N-Lysine Methyltransferase FAM173B; Prev. FAM173B; Family With Sequence Similarity 173, Member B; JS-2; Protein FAM173B; ATP synthase Subunit C Lysine N-Methyltransferase; LOC134145; Family With Sequence Similarity 173 Member B; ATP Synt
Species:
Mouse
Source:
E. coli Cell-free
Cat. No.: HY-11001R
CAS No.: 718630-59-2
Target:
Research Areas:
PHA-793887 (Standard) is the analytical standard of PHA-793887 (HY-11001). This product is intended for research and analytical applications. PHA-793887 is a potent, ATP-competitive CDK inhibitor, can inhibit Cdk2, Cdk1, Cdk4, and Cdk9 with IC50s of 8 nM, 60 nM, 62 nM and 138 nM, respectively, and also inhibits glycogen synthase Kinase 3β with an IC50 of 79 nM.
Cat. No.: HY-P812033
Synonyms: ATP6V1E1; ATPase H+ Transporting V1 Subunit E1; ATP6E2; P31; ATP6E; Vma4; ATPase, H+ Transporting, Lysosomal 31kDa, V1 Subunit E1; V-Type Proton ATPase Subunit E 1; Vacuolar Proton Pump Subunit E 1; V-ATPase 31 KDa Subunit; V-ATPase Subunit E 1; ATP6V1E; ATPase, H+ Transporting, Lysosomal 31kDa, V1 Subunit E Isoform 1; ATPase, H+ Transporting, Lysosomal (Vacuolar Proton Pump) 31kD; H(+)-Transporting Two-Sector ATPase, 31kDa Subunit; H+-Transporting ATP synthase Chain E, Vacuolar; V-ATPase Subunit E1; V-ATPase, Subunit E; ARCL2C
Cat. No.: HY-P812033A
Synonyms: ATP6V1E1; ATPase H+ Transporting V1 Subunit E1; ATP6E2; P31; ATP6E; Vma4; ATPase, H+ Transporting, Lysosomal 31kDa, V1 Subunit E1; V-Type Proton ATPase Subunit E 1; Vacuolar Proton Pump Subunit E 1; V-ATPase 31 KDa Subunit; V-ATPase Subunit E 1; ATP6V1E; ATPase, H+ Transporting, Lysosomal 31kDa, V1 Subunit E Isoform 1; ATPase, H+ Transporting, Lysosomal (Vacuolar Proton Pump) 31kD; H(+)-Transporting Two-Sector ATPase, 31kDa Subunit; H+-Transporting ATP synthase Chain E, Vacuolar; V-ATPase Subunit E1; V-ATPase, Subunit E; ARCL2C
Cat. No.: HY-187680
Target:
Research Areas:
GSK-3β-IN-30 is a glycogen synthase kinase-3β (GSK-3β) inhibitor. GSK-3β-IN-30 stabilizes its conformation in the binding pocket by occupying the ATP-binding cleft of GSK-3β, forming hydrogen bonds with Lys183 and Ser203, and establishing π-anion interactions with Asp181 and Asp200. GSK-3β-IN-30 can be used for the research of Alzheimer's disease .
Cat. No.: HY-187681
CAS No.: 889768-87-0
Target:
Research Areas:
GSK-3β-IN-31 is a glycogen synthase kinase-3β (GSK-3β) inhibitor. GSK-3β-IN-31 binds to the ATP-binding pocket of GSK-3β, forms hydrogen bonds with Lys183 and Ser203, and also engages in π-anion interactions with Asp181 and Asp200 to stabilize the binding conformation. GSK-3β-IN-31 can be used for the research of Alzheimer's disease .
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
